Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion.
Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1491-1500. doi: 10.1007/s00417-021-05494-5. Epub 2021 Nov 29.
Graefes Arch Clin Exp Ophthalmol. 2022.
PMID: 34842984
Free PMC article.
Clinical Trial.
Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial.
Khurana RN, Oden NL, VanVeldhuisen PC, Scott IU, Blodi BA, Ip MS; SCORE2 Investigator Group.
Khurana RN, et al.
Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1839-1851. doi: 10.1007/s00417-020-05018-7. Epub 2021 Jan 7.
Graefes Arch Clin Exp Ophthalmol. 2021.
PMID: 33415354
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite